XML 31 R20.htm IDEA: XBRL DOCUMENT v3.19.2
SHAREHOLDERS' EQUITY (DEFICIT) (Tables)
6 Months Ended
Jun. 30, 2019
Stockholders Equity Note [Line Items]  
Schedule of summary of the outstanding stock options
    Number     Weighted           Weighted        
    Of Shares     Average     Weighted     Average     Aggregate  
    Underlying     Exercise     Average     Remaining     Intrinsic  
    Options     Price     Fair Value     Contractual Life     Value (1)  
                              (in years)          
Outstanding at December 31, 2018     700,000     $ 0.10     $ 0.05       2.0     $            -  
                                         
For the period ended June 30, 2019                                        
Granted     -       -       -                  
Exercised     -       -       -                  
Expired     (125,000 )     0.10       -                  
                                         
Outstanding at June 30, 2019     575,000     $ 0.10     $ 0.05       1.7     $ -  
Outstanding and exerciseable at June 30, 2019     575,000     $ 0.10     $ 0.05       1.7     $ -  

 

(1) The aggregate intrinsic value is based on the $0.0477 closing price as of June 30, 2019, for the Company’s Common Stock.

Series A Preferred Stock Warrants  
Stockholders Equity Note [Line Items]  
Schedule of outstanding stock warrants
          Weighted  
    Common     Average  
    Stock     Exercise  
    Warrants     Price  
Outstanding and exercisable at December 31, 2018     25,000     $ 4.00  
                 
For the period ended June 30, 2019                
Issued     -       -  
Exercised     -       -  
Expired     -       -  
Outstanding and exercisable at June 30, 2019     25,000     $ 4.00  
Series B Preferred Stock Warrants  
Stockholders Equity Note [Line Items]  
Schedule of outstanding stock warrants
          Weighted  
    Preferred     Average  
    Stock     Exercise  
    Warrants     Price  
Outstanding and exercisable at December 31, 2018     2,820,000     $ 3.00  
                 
For the period ended  June 30, 2019                
Granted     -       -  
Exercised     -       -  
Expired     (2,780,000 )     -  
Outstanding and exerciseable at June 30, 2019     40,000     $ 3.00